Phreesia, Inc. (PHR) is set to report third-quarter earnings results after the closing bell on Monday, December 8, and Wall Street's most accurate analysts have been busy adjusting their forecasts ahead of the announcement.

The consensus view calls for the Wilmington, Delaware-based healthcare software company to post earnings of 24 cents per share, which would represent a substantial jump from the 4 cents per share reported in the same quarter last year. Analysts are also expecting revenue of $120.03 million, compared to $106.8 million in the prior-year period.

The company last reported on September 4, delivering mixed results for its second quarter. Phreesia shares edged up 0.8% to close at $20.55 on Thursday.

What the Smart Money Is Saying

Several analysts with proven track records have weighed in on Phreesia recently, and the sentiment skews decidedly bullish. Here's what the most accurate forecasters are projecting:

JMP Securities analyst Silvan Tuerkcan, who maintains a 65% accuracy rate, kept his Market Outperform rating on September 8, 2025, while bumping his price target from $30 to $34.

Needham analyst Ryan MacDonald, with a 56% accuracy rate, maintained a Buy rating and lifted his target from $29 to $35 on September 5, 2025.

Mizuho analyst Steven Valiquette initiated coverage on August 27, 2025, with an Outperform rating and a $36 price target. This analyst also carries a 56% accuracy rate.

Keybanc analyst Aleksey Yefremov maintained his Overweight rating on July 14, 2025, and raised his price target from $28 to $35. His accuracy rate stands at 57%.

DA Davidson analyst Robert Simmons maintained a Buy rating on April 14, 2025, though he trimmed his price target from $36 to $34. This analyst has a 52% accuracy rate.

The Street's optimism suggests investors should keep a close eye on Monday's earnings call to see if the company can deliver on these elevated expectations.